Long-term effects of exenatide therapy over 82 weeks on glycaemic control and weight in over-weight metformin-treated patients with type 2 diabetes mellitus.

Ratner, R E

Long-term effects of exenatide therapy over 82 weeks on glycaemic control and weight in over-weight metformin-treated patients with type 2 diabetes mellitus. [electronic resource] - Diabetes, obesity & metabolism Jul 2006 - 419-28 p. digital

Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

1462-8902

10.1111/j.1463-1326.2006.00589.x doi


Adult
Aged
Cardiovascular Diseases--etiology
Diabetes Mellitus, Type 2--blood
Double-Blind Method
Drug Therapy, Combination
Exenatide
Female
Glycated Hemoglobin--metabolism
Humans
Hypoglycemic Agents--adverse effects
Lipids--blood
Male
Metformin--therapeutic use
Middle Aged
Overweight--drug effects
Peptides--adverse effects
Risk Factors
Venoms--adverse effects
Weight Loss--drug effects